Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,144 | -217,201 | 36,908 | -102,496 | -88,720 |
| Depreciation Amortization | 32,111 | 126,710 | 128,303 | 124,917 | 127,048 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 23,632 |
| Accounts receivable | 19,800 | -5,533 | 35,271 | 30,107 | -30,902 |
| Other Working Capital | -52,636 | -606 | -107,198 | 18,338 | -17,073 |
| Other Operating Activity | -36,703 | 187,105 | -20,787 | -8,699 | 57,278 |
| Operating Cash Flow | $-65,572 | $90,475 | $72,497 | $62,167 | $71,263 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 499,216 | -1,481 | -5,282 | 66,171 | -2,860 |
| Net Acquisitions | 7,585 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -12,065 | 0 | -8,277 | -68,818 |
| Sale Of Investment | 6,000 | 12,065 | -1,800 | 0 | 117,214 |
| Investing Cash Flow | $512,801 | $-1,481 | $-7,082 | $57,894 | $45,536 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -461,256 | -150,000 | -82,500 | -110,000 | -100,000 |
| Common Stock Issued | 88 | 251 | 2,020 | 8,940 | 9,951 |
| Other Financing Activity | -7,382 | -8,087 | -870 | -9,826 | -10,125 |
| Financing Cash Flow | $-468,550 | $-157,836 | $-81,350 | $-110,886 | $-100,174 |
| Beginning Cash Position | 42,107 | 110,949 | 126,884 | 117,709 | 101,084 |
| End Cash Position | 20,786 | 42,107 | 110,949 | 126,884 | 117,709 |
| Net Cash Flow | $-21,321 | $-68,842 | $-15,935 | $9,175 | $16,625 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,572 | 90,475 | 72,497 | 62,167 | 71,263 |
| Capital Expenditure | -10 | -1,481 | -5,507 | -666 | -2,860 |
| Free Cash Flow | -65,582 | 88,994 | 66,990 | 61,501 | 68,403 |